Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/1FD01EB2.svg?ark=w1%2F20260526%2F1FD01EB2)](https://nobleid.org/work/w1/20260526/1FD01EB2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors